Procter & Gamble is expected to report Q3 2026 revenue of $22.02 billion and EPS of $1.89, with the current share price of $172.50 trailing the average analyst price target of $184.00. The central focus for investors is organic volume growth, as the market looks for evidence that the company can grow its consumer base without relying solely on price hikes.
While P&G has successfully navigated inflationary pressures, analysts are concerned that continued pricing adjustments may finally be eroding market share in the grooming and baby care segments. Management’s commentary on commodity cost headwinds and the strength of the consumer in China will be pivotal for maintaining the stock's premium valuation.